Johns Hopkins School of Medicine, United States of America
Mobile DNA is an online, peer-reviewed, open access journal that publishes articles providing novel insights into DNA rearrangements in all organisms, ranging from transposition and other types of recombination mechanisms to patterns and processes of mobile element and host genome evolution. In addition, the journal will consider articles on the utility of mobile genetic elements in biotechnological methods and protocols.
The average time from submission to a first decision is 24 days.
Professor Nancy Craig is a geneticist whose research interests include the mechanisms and control of transpositions and site-specific recombinations, protein - DNA interactions, and the molecular genetics of bacteria.
After gaining a PhD from Cornell University in 1980, Professor Craig undertook post doc work in the Laboratory of Dr. Howard A. Nash, Laboratory of Neurochemistry, NIH, before moving to the University of California San Francisco in 1984. In 1995, she became a Professor in the Department of Molecular Biology and Genetics at The Johns Hopkins University School of Medicine and an Investigator for the Howard Hughes Medical Institute.
Professor Craig has received several awards and honors over the years including serving on the Board of Directors of the Genetics Society of America (1996-1999), being awarded a Fellowship in the American Academy of Microbiology (1996) and being Elected as a Fellow of the American Academy of Arts and Sciences (2007).
Professor Craig's current work is focused on understanding several specific transposons, including Tn7, a transposable element found in bacteria, which displays unusual target selectivity. Most transposable elements display only modest site selectivity, inserting into many different target sites, while Tn7 inserts into a single specific site in the chromosomes of many bacteria. Understanding the molecular mechanisms by which transposable elements move could impact on several related areas, including genetic engineering, evolution and the treatment of retroviruses, including HIV.